Suchergebnisse - "quality of survival"

Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa—Results of the HIT 2000 trial

Autoren: Martin Mynarek Anne Rossius Anika Guiard et al.

Quelle: Neuro-Oncology 26(11), 2113-2124 (2024). doi:10.1093/neuonc/noae092
Mynarek, M, Rossius, A, Guiard, A, Ottensmeier, H, von Hoff, K, Obrecht-Sturm, D, Bußenius, L, Friedrich, C, von Bueren, A O, Gerber, N U, Traunwieser, T, Kortmann, R-D, Warmuth-Metz, M, Bison, B, Thomale, U-W, Krauss, J, Pietsch, T, Clifford, S C, Pfister, S M, Sturm, D, Sahm, F, Tischler, T & Rutkowski, S 2024, ' Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial ', Neuro-Oncology . https://doi.org/10.1093/neuonc/noae092

Schlagwörter: Male, Mutism / etiology, quality of survival, ependymoma, Adolescent, Mutism, Cancer Survivors / psychology, etiology [Hydrocephalus], etiology [Mutism], Infratentorial Neoplasms, Neuropsychological Tests, Cognition Disorders / etiology, medulloblastoma, Cancer Survivors, Risk Factors, Infratentorial Neoplasms / therapy, Humans, ddc:610, Child, statistics & numerical data [Cancer Survivors], Ependymoma / therapy, 2. Zero hunger, neuropsychological late effects, Infant, etiology [Cognition Disorders], Neuropsychological late effects, Hydrocephalus / etiology, therapy [Medulloblastoma], Prognosis, Quality of survival, infant, 3. Good health, Ependymoma, Child, Preschool, therapy [Infratentorial Neoplasms], psychology [Cancer Survivors], Medulloblastoma / therapy, Female, Cancer Survivors / statistics & numerical data, Cognition Disorders, therapy [Ependymoma], Medulloblastoma, Follow-Up Studies, Hydrocephalus

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38835160

Effects of a systematic nursing model based on the concept of colour psychology on the psychological and survival quality of brain glioma

Autoren: XU Qunge FAN Yueyue WU Yuyan et al.

Quelle: Zhongguo linchuang yanjiu, Vol 37, Iss 12, Pp 1969-1974 (2024)

Schlagwörter: quality of survival, brain glioma, Medicine, systematic care, psychological state, color psychology

Zugangs-URL: https://doaj.org/article/bf9fd1e8026e41a7bb961597e3981d7d

The impact of quality of survival on the mental state of lung cancer patients: A cross-sectional clinical survey

Autoren: Dakai Qin Xiaojun Xia Maoqin Yang et al.

Quelle: Asian Journal of Surgery, Vol 46, Iss 7, Pp 2816-2818 (2023)

Schlagwörter: 0301 basic medicine, Lung Neoplasms, RD1-811, Correlation analysis, Mental status, Quality of survival, 03 medical and health sciences, Cross-Sectional Studies, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Quality of Life, Humans, Surgery, Lung cancer

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36737326
https://doaj.org/article/cc96c7bfb047439fbb5b955117bf8d96

Overview of European standard clinical practice recommendations for multidiscplinary teams involved in the treatment of central nervous system tumours in children and adolescents – SIOPE Brain Tumour Group

Autoren: Otth, Maria Scheinemann, Katrin Ajithkumar, Thankamma et al.

Weitere Verfasser: Otth, Maria Scheinemann, Katrin Ajithkumar, Thankamma et al.

Schlagwörter: Central nervous system tumour, child, endocrinology, neuro-ophthalmology, neuropathology, neuroradiology, neurosurgery, quality of survival, radiotherapy, recommendation, Oncology, Dentistry (miscellaneous)

Dateibeschreibung: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/452920

Verfügbarkeit: https://dspace.library.uu.nl/handle/1874/452920

Key Questions on the Long-Term Utility of Methylphenidate in Paediatric Brain Tumour Survivorship: A Retrospective Clinical Case Series

Autoren: Alexander J. Hagan Sarah J. Verity

Quelle: Children, Vol 11, Iss 2, p 187 (2024)

Schlagwörter: brain tumour, cancer, quality of survival, survivorship, methylphenidate, cognition, Pediatrics, RJ1-570

Relation: https://www.mdpi.com/2227-9067/11/2/187; https://doaj.org/toc/2227-9067; https://doaj.org/article/5f117b05ba4a4381862329a5e9ba16ac

Verfügbarkeit: https://doi.org/10.3390/children11020187
https://doaj.org/article/5f117b05ba4a4381862329a5e9ba16ac

Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years

Autoren: Sophie Thomas Kim Bull Helen Spoudeas et al.

Weitere Verfasser: Sophie Thomas Kim Bull Helen Spoudeas et al.

Quelle: European Journal of Paediatric Neurology. 25:59-67

Schlagwörter: Clinical Trials as Topic, Brain Neoplasms, Late effects, Young children, Clinical Neurology, Infant, Assessment, Quality of survival, 3. Good health, Brain tumor, Europe, 03 medical and health sciences, 0302 clinical medicine, Child, Preschool, Journal Article, Quality of Life, Humans, Female, Pediatrics, Perinatology, and Child Health, Child, Infants

Dateibeschreibung: application/pdf; text

Zugangs-URL: https://eprints.soton.ac.uk/435172/1/QOS_under_5_years_version_for_resubmission_021019.docx
https://pubmed.ncbi.nlm.nih.gov/31753708
https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=202002246270556344
https://www.ncbi.nlm.nih.gov/pubmed/31753708
https://www.sciencedirect.com/science/article/pii/S1090379819303915
https://dspace.library.uu.nl/handle/1874/439096
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/77600
https://doi.org/10.1016/j.ejpn.2019.10.002
https://eprints.soton.ac.uk/435172/

Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) for Lenvatinib plus Everolimus Versus Everolimus Monotherapy in Patients with Advanced Renal Cell Carcinoma

Autoren: Chung-Han Lee Yin Wan Alan Smith et al.

Quelle: European Urology Open Science, Vol 31, Iss , Pp 1-9 (2021)

Schlagwörter: Lenvatinib, Quality-adjusted survival, Q-TWiST, Renal cell carcinoma, Targeted therapy, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Dateibeschreibung: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266616832100118X; https://doaj.org/toc/2666-1683

Zugangs-URL: https://doaj.org/article/b59061bead43495e8d98daf1f11e100d

Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials

Autoren: Thomas, Sophie Embry, Leanne Walsh, Karin et al.

Quelle: Pediatric Blood & Cancer. 70

Schlagwörter: quality of survival, paediatric, CHILDREN, Medical Oncology, Pediatrics, cognitive, 03 medical and health sciences, Cognition, 0302 clinical medicine, QUALITY-OF-LIFE, 3211 Oncology and carcinogenesis, Neoplasms, cancer, late effects, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, brain tumour, Child, SURVIVORS, child, Science & Technology, 1103 Clinical Sciences, Hematology, 3213 Paediatrics, 3. Good health, Europe, Oncology, 1114 Paediatrics and Reproductive Medicine, Life Sciences & Biomedicine

Dateibeschreibung: text

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36734371
https://eprints.soton.ac.uk/473707/

The Impact of Triangle Hierarchical Management on Self-Management Behavior and Quality of Survival in Parkinson's Patients

Autoren: Yahua Zeng Jianghua Huang Xuan Tang et al.

Quelle: Frontiers in Surgery, Vol 9 (2022)

Schlagwörter: Parkinson's, Triangle, tiered management, self-management behavior, quality of survival, Surgery, RD1-811

Dateibeschreibung: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fsurg.2022.878477/full; https://doaj.org/toc/2296-875X

Zugangs-URL: https://doaj.org/article/23708bc145dd44e58b7f61b2556f8359

Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy

Autoren: Mantovani, Lorenzo Giovanni Cortesi, Paolo Angelo Cardillo, Alessandra et al.

Quelle: Farmeconomia. Health economics and therapeutic pathways; Vol 23, No 1 (2022) ; 2240-256X

Schlagwörter: Dimethyl Fumarate, Teriflunomide, Relapsing-Remitting Multiple Sclerosis, Cost-Effectiveness, Quality-Adjusted Survival

Dateibeschreibung: text/html; application/pdf

Relation: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1510/1891; https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1510/1892; https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1510

Verfügbarkeit: https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1510
https://doi.org/10.7175/fe.v23i1.1510

Semiparametric Estimation of Marginal Mark Distribution

Autoren: Huang, Yijian Berry, Kristin

Quelle: Biometrika, 2006 Dec 01. 93(4), 895-910.

Zugangs-URL: https://www.jstor.org/stable/20441334

Integrating Health Profile with Survival for Quality of Life Assessment [with Commentary and Rejoinder]

Autoren: Hwang, Jing-Shiang Wang, Jung-Der

Quelle: Quality of Life Research, 2004 Feb 01. 13(1), 1-14.

Zugangs-URL: https://www.jstor.org/stable/4038134

Experimental Evidence for Food Limitation and Sex-Specific Strategies of American Kestrels (Falco sparverius) Provisioning Offspring

Autoren: Dawson, Russell D. Bortolotti, Gary R.

Quelle: Behavioral Ecology and Sociobiology, 2002 Jun 01. 52(1), 43-52.

Zugangs-URL: https://www.jstor.org/stable/4602104

Evaluating High Dose Therapy in Multiple Myeloma: Use of Quality-Adjusted Survival Analysis

Autoren: Chevret, S.

Quelle: Quality of Life Research, 2002 Mar 01. 11(2), 91-99.

Zugangs-URL: https://www.jstor.org/stable/4037469

A healthier society with sugar restriction plan from childhood

Autoren: Hiroshi Bando

Quelle: Asploro Journal of Biomedical and Clinical Case Reports. 2:1-3

Schlagwörter: Sugar-Sweetened Beverages, 2. Zero hunger, 03 medical and health sciences, Low Carbohydrate Diet, 0302 clinical medicine, Quality-Adjusted Survival Years, Artificially Sweetened Beverages, National Diet and Nutrition Survey, Meal Tolerance Test, 3. Good health

Zugangs-URL: https://asploro.com/wp-content/uploads/2019/07/A-healthier-society-with-sugar-restriction-plan-from-childhood.pdf
https://repo.lib.tokushima-u.ac.jp/files/public/11/113863/20191028112526494717/asjbccr_2_2_1.pdf
https://asploro.com/wp-content/uploads/2019/07/A-healthier-society-with-sugar-restriction-plan-from-childhood.pdf
http://repo.lib.tokushima-u.ac.jp/113863
https://asploro.com/a-healthier-society-with-sugar-restriction-plan-from-childhood/

Nonparametric Estimation of the Joint Distribution of Survival Time and Mark Variables

Autoren: Huang, Yijian Louis, Thomas A.

Quelle: Biometrika, 1998 Dec 01. 85(4), 785-798.

Zugangs-URL: https://www.jstor.org/stable/2337483

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis

Autoren: Berry, Vincent Basson, Laurent Bogart, Emilie et al.

Weitere Verfasser: Berry, Vincent Basson, Laurent Bogart, Emilie et al.

Quelle: Cancer

Schlagwörter: Leiomyosarcoma, Male, [SDV]Life Sciences [q-bio], Mesh:Diarrhea/chemically induced, 0302 clinical medicine, Mesh:Alopecia/chemically induced, Mesh:Phenylurea Compounds/therapeutic use, Mesh:Aged, Mesh:Synovial/drug therapy, Mesh:Treatment Outcome, Mesh:Anorexia/chemically induced, Liposarcoma, Middle Aged, 16. Peace & justice, Anorexia, 3. Good health, [SDV] Life Sciences [q-bio], Hospitalization, Mesh:Quality of Life, Hypertension, Female, Hand-Foot Syndrome, Mesh:Proportional Hazards Models, Mesh:Severity of Illness Index, Mesh:Female, Diarrhea, Mucositis, quality-adjusted survival, Mesh:Fecal Incontinence/chemically induced, Mesh:Male, Antineoplastic Agents, Mesh:Sarcoma, 03 medical and health sciences, Double-Blind Method, quality-adjusted time without symptoms of progression or toxicity (Q-TWiST), Mesh:Middle Aged, Mesh:Asthenia/chemically induced, Mesh:Liposarcoma/drug therapy, Humans, metastatic soft-tissue sarcoma, placebo, regorafenib, Mesh:Hospitalization, Mesh:Mucositis/chemically induced, Mesh:Sarcoma/drug therapy, Mesh:Hand-Foot Syndrome/etiology, Aged, Proportional Hazards Models, Mesh:Pyridines/therapeutic use, Phenylurea Compounds, Mesh:Antineoplastic Agents/therapeutic use, Alopecia, Original Articles, Mesh:Leiomyosarcoma/drug therapy, Mesh:Humans, Asthenia, Mesh:Hypertension/chemically induced, Fecal Incontinence, Mesh:Double-Blind Method

Dateibeschreibung: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Zugangs-URL: https://acsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.30661
https://pubmed.ncbi.nlm.nih.gov/28295221
https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30661
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485075
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30661
https://europepmc.org/articles/PMC5485075
https://pubmed.ncbi.nlm.nih.gov/28295221/
https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.30661
http://hdl.handle.net/20.500.12210/17207
https://hal.univ-lille.fr/hal-02638646v1
https://doi.org/10.1002/cncr.30661
https://hal.univ-lille.fr/hal-02638646v1/document

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial

Autoren: Rolf-Dieter Kortmann Colin R. Kennedy Virginie Kieffer et al.

Weitere Verfasser: Rolf-Dieter Kortmann Colin R. Kennedy Virginie Kieffer et al.

Quelle: Neuro-Oncology Practice. 4:161-170

Schlagwörter: [SCCO]Cognitive science, quality of survival, 03 medical and health sciences, 0302 clinical medicine, intellectual ability, outcome, everyday executive functioning, [SCCO] Cognitive science, medulloblastoma, 3. Good health

Dateibeschreibung: application/pdf; text

Zugangs-URL: https://academic.oup.com/nop/article-pdf/4/3/161/29005654/npw028.pdf
https://pubmed.ncbi.nlm.nih.gov/31385949
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655414/
https://moh-it.pure.elsevier.com/en/publications/quality-of-survival-and-cognitive-performance-in-children-treated
https://pubmed.ncbi.nlm.nih.gov/31385949/
https://academic.oup.com/nop/article/4/3/161/2982364
https://europepmc.org/article/MED/31385949
http://academic.oup.com/nop/article/4/3/161/2982364
https://eprints.soton.ac.uk/406151/

Regosarc: regorafenib versus placebo in doxorubicin-refractory soft-tissue sarcoma-a quality-adjusted time without symptoms of progression or toxicity analysis

Autoren: Berry, Vincent Basson, Laurent Bogart, Emilie et al.

Weitere Verfasser: Berry, Vincent Basson, Laurent Bogart, Emilie et al.

Schlagwörter: quality-adjusted time without symptoms of progression or toxicity (Q-TWiST), metastatic soft-tissue sarcoma, placebo, quality-adjusted survival, regorafenib, Mesh:Hypertension/chemically induced, Mesh:Liposarcoma/drug therapy, Mesh:Treatment Outcome, Mesh:Severity of Illness Index, Mesh:Sarcoma, Mesh:Synovial/drug therapy, Mesh:Sarcoma/drug therapy, Mesh:Quality of Life, Mesh:Male, Mesh:Middle Aged, Mesh:Mucositis/chemically induced, Mesh:Phenylurea Compounds/therapeutic use, Mesh:Proportional Hazards Models, Mesh:Pyridines/therapeutic use, Mesh:Leiomyosarcoma/drug therapy, Mesh:Aged, Mesh:Alopecia/chemically induced, Mesh:Anorexia/chemically induced, Mesh:Antineoplastic Agents/therapeutic use, Mesh:Asthenia/chemically induced, Mesh:Diarrhea/chemically induced, Mesh:Double-Blind Method, Mesh:Fecal Incontinence/chemically induced, Mesh:Female, Mesh:Hand-Foot Syndrome/etiology

Dateibeschreibung: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Relation: Cancer; http://hdl.handle.net/20.500.12210/17207

Verfügbarkeit: https://hdl.handle.net/20.500.12210/17207

Quality-Adjusted Time without Symptoms or Toxicity: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma: Analysis of Axicabtagene Ciloleucel versus Standard of Care in Patients with Relapsed/Refractory Large B Cell Lymphoma

Autoren: Marie José Kersten Yao Qiao Ruchit Shah et al.

Quelle: Transplantation and Cellular Therapy. 29:335.e1-335.e8

Schlagwörter: Quality of life, Relapsed or refractory large B cell lymphoma, Quality-adjusted time without symptoms or toxicity, Hematopoietic Stem Cell Transplantation, Quality-adjusted survival, Standard of Care, Transplantation, Autologous, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Child, Preschool, Quality of Life, Disease Progression, Axicabtagene ciloleucel, Humans, Lymphoma, Large B-Cell, Diffuse

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/36646322